18th week of 2009 patent applcation highlights part 38 |
Patent application number | Title | Published |
20090110577 | VARIABLE DELIVERY VANE OIL PUMP, IN PARTICULAR FOR OIL - A variable delivery vane pump, in particular for oil, is provided with a stator ( | 2009-04-30 |
20090110578 | PROGRESSING CAVITY PUMP WITH SPLIT STATOR - A progressing cavity pump system including a rotor and a stator having an inner cavity. The rotor is rotationally disposed inside the inner cavity of the stator such that rotation of the rotor relative to the stator causes material in the inner cavity to be pumped through the stator. The stator includes at least two radially separable stator portions such that when at least one of the stator portions is removed, at least one of the rotor or the inner cavity is exposed. | 2009-04-30 |
20090110579 | EQUAL WALL STATOR - A method for making a stator assembly including the steps of providing a generally cylindrical stator casing, hydroforming the stator casing into a generally helical shape, and positioning a stator liner having a generally helical shape inside the stator casing. | 2009-04-30 |
20090110580 | Scroll type fluid machine - The present invention provides a scroll type fluid machine realizing reduced attachment space in a casing and improvement in workability at the time of assembly and the like by using a plurality of ball coupling mechanisms. A plurality of ball coupling mechanisms are disposed between a casing and a rear side of an orbiting scroll. Each of the ball coupling mechanisms includes first and second thrust receivers (reception plates), a sphere, and a cylindrical ring. A thrust load to be applied to an end plate of the orbiting scroll is received between the first and second thrust receivers (reception plates) and the sphere. The cylindrical ring disposed between the first and second thrust receivers displays a so-called rotation preventing effect in such a manner that its outer peripheral surface makes a rolling contact with inner peripheral surfaces of cylindrical portions in association with an orbiting motion of the orbiting scroll. | 2009-04-30 |
20090110581 | Scroll Compressor For Carbon Dioxide Refrigerant - A scroll machine is provided with wear resistant features to provide the scroll machine with improved operation when processing CO | 2009-04-30 |
20090110582 | VANE MACHINE - A vane machine according to the invention comprises a housing ( | 2009-04-30 |
20090110583 | Rotary blower with super-charged injection cooling - This invention involves a rotary blower with super-charged injection cooling having multiple interconnected and synchronized parallel multi-lobe rotors with the same number of lobes for propelling flow from a suction port to a discharge port of an inner casing without using internal compression. The embodiments incorporate manifolds near the blower discharge port acting as super-charging inlet port injecting air at the elevated pressure over the blower discharge pressure to cool the impellers and internal casing. The cooling air supply could be piped from an external compressed air source or could be generated by one or more fans mounted on the rotors own shafts. | 2009-04-30 |
20090110584 | High pressure telescoping gear pumps and motors - Rotary seals in a telescoping gear pump/motor a feature that allows the seal to shift radially relative to other components while maintaining the seal integrity and without compromising the function of the bearings or the bushings needed to bear the load. | 2009-04-30 |
20090110585 | REFRIGERANT COMPRESSOR ARRANGEMENT - The invention concerns a refrigerant compressor arrangement with a compressor unit ( | 2009-04-30 |
20090110586 | Refrigerant compressor - A hermetically encapsulated refrigerant compressor which comprises a hermetically sealed compressor housing ( | 2009-04-30 |
20090110587 | Method for manufacturing laminated soft-magnetic sheet - A method for producing a laminated soft-magnetic sheet is provided by laminating thin soft-magnetic sheets produced by an application method. A change in sheet thickness can be suppressed and variations in the magnetic permeability are small. The method for manufacturing a laminated soft-magnetic sheet includes the step (A) of obtaining curable soft-magnetic sheets, each of the curable soft-magnetic sheets being produced by applying to a release base a soft-magnetic composition prepared by mixing at least a flat soft-magnetic powder, an acrylic rubber having a glycidyl group, an epoxy resin, a latent curing agent for the epoxy resin, and a solvent, drying the applied soft-magnetic composition at a temperature T | 2009-04-30 |
20090110588 | STAINLESS STEEL HAVING A HIGH HARDNESS AND EXCELLENT MIRROR-FINISHED SURFACE PROPERTY, AND METHOD OF PRODUCING THE SAME - Disclosed is a stainless steel containing, by mass, 0.05% or less carbon, 1.5 to smaller than 3.5% Si, 3.0% or less Mn, 6.0 to 12.0% Cr, 4.0 to 10.0% Ni, 10.0% or less Co, 6.0% or less Cu, 0.5 to 3.0% Ti, 0 to 2.0% Al, less than 0.4% Mo, not more than 0.01% nitrogen, and the balance of Fe and unavoidable impurities. Preferably, it has a hardness of not lower than 59 HRC and may contain not more than 1.0% Nb and/or not more than 1.0% Ta. Alternatively, the stainless steel may further contain not more than 0.1% of Zr. The process for producing the steel includes producing a steel having a composition as described above by a consumable electrode remelting process, and then subjecting the steel to a solution treatment at a temperature of 1000 to 1150° C. and an aging treatment at a temperature of 400 to 550° C., thereby aging the stainless steel to a hardness of not lower than 59 HRC. | 2009-04-30 |
20090110589 | Steel Material and Process for Producing the Same - A steel material of 85 to 95 H | 2009-04-30 |
20090110590 | COOKING DEVICE WITH DEODORIZATION - A cooking device includes a cooking chamber; a first deodorization region along which air from the cooking chamber flows and in which a plasma discharge is generated for removing odor-producing materials generated in the cooking chamber from the air; and a bypass region along which air from the cooking chamber flows to bypass the first deodorization region. | 2009-04-30 |
20090110591 | STRESS-INDUCED BANDGAP-SHIFTED SEMICONDUCTOR PHOTOELECTROLYTIC/PHOTOCATALYTIC/PHOTOVOLTAIC SURFACE AND METHOD FOR MAKING SAME - Titania is a semiconductor and photocatalyst that is also chemically inert. With its bandgap of 3.0, to activate the photocatalytic property of titania requires light of about 390 nm wavelength, which is in the ultra-violet, where sunlight is very low in intensity. A method and devices are disclosed wherein stress is induced and managed in a thin film of titania in order to shift and lower the bandgap energy into the longer wavelengths that are more abundant in sunlight. Applications of this stress-induced bandgap-shifted titania photocatalytic surface include photoelectrolysis for production of hydrogen gas from water, photovoltaics for production of electricity, and photocatalysis for detoxification and disinfection. | 2009-04-30 |
20090110592 | COOKING DEVICE WITH DEODORIZATION - A cooking device includes an inner case, a cooking chamber within the inner case and an odor removal unit configured to generate a plasma discharge for removing odor-producing materials from the cooking chamber. | 2009-04-30 |
20090110593 | Foamed Materials Based on Aminoplasts as Sterilizable Raw Materials - Use of an open-celled foam based on an aminoplastic as sterilizable working material, and also methods of sterilizing the open-celled foam by impregnation with a microbicidal liquid such as alcohol or formalin, methods of sterilizing working vessels for medical or microbiological work and for decontaminating material contaminated with micro-organisms at temperatures above 100° C. | 2009-04-30 |
20090110594 | DISH WASHER WITH UV STERILIZATION DEVICE THEREIN - A dish washer and a control method thereof are disclosed. The dish washer includes a UV sterilization device ( | 2009-04-30 |
20090110595 | Decontamination method and system implementing it - The method of microbiological decontamination of a machine comprising an enclosure ( | 2009-04-30 |
20090110596 | Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant - Sterilization methods and apparatus are effective to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores, i.e., | 2009-04-30 |
20090110597 | Apparatus for Execution of Treatment Operations on Microscope Slides with Tissue Specimens - An apparatus for automatic execution of different treatment operations in connection with staining of tissue specimens on microscope slides, wherein the apparatus ( | 2009-04-30 |
20090110598 | FULLY AUTOMATED MICROARRAY PROCESSING SYSTEM - An automated microarray processing system includes a microarray housing assembly module, an incubation module, a washing module and at least one automated transport module. With the automated transport module being mechanically moved among the microarray housing assembly module, the incubation module and the washing module, biochemical reaction of a reaction region of a microarray and a biological sample solution disposed therebetween is automatically performed, and the reacted microarray is automatically cleaned when the biochemical reaction of the microarray is completed. | 2009-04-30 |
20090110599 | METHODS OF OPERATING FILM SURFACE REACTORS AND REACTORS EMPLOYING SUCH METHODS - In new methods of operating surface reactors, and new reactors employing such methods, the reactor comprises a cylindrical rotor and a cylindrical stator coaxial with one another with respective cylindrical faces forming an annular reaction chamber between them, the chamber being filled with air or inert gas constituting a shear transmitting fluid. The volume of the reactants, one of which at least must be in liquid state, fed into the chamber is only such that they will immediately be spread out under centrifugal force on the stator surface by the shear transmitting fluid in the form of a film of thickness not more than 150 micrometers, preferably not more than 120 micrometers, and more preferably less than 100 micrometers. The rotor is rotated at high speed, usually about 30,00 to 80,000 rpm, and at these speeds molecular clusters which normally slow down one on one molecular encounters between the reactant molecules, are disrupted by the high shear to facilitate forced, uniform molecular interdiffusion, so that the molecules more aggressively and quickly interact with one another with considerably increased rates of reaction, e.g 100 to 1,000 times increase. This use of an intermediate shear transmitting gaseous fluid gives flexibility in the radial dimension of the reaction chamber, which can be 1 mm or larger, avoiding the need for a reaction chamber of radial dimension corresponding to the desired film thickness and its attendant difficulties, due for example to differential expansion of the rotor and stator with rotation and temperature changes. | 2009-04-30 |
20090110600 | METHODS OF OPERATING FILM SURFACE REACTORS AND REACTORS EMPLOYING SUCH METHODS - In new methods of operating surface reactors, and new reactors employing such methods, the reactor comprises a helical reaction chamber formed as a coil surrounding a tubular support, or a groove machined in a cylindrical body. The passage is supplied with a high velocity flow of air or inert gas constituting a shear transmitting fluid that immediately spreads the reactants, one of which at least must be in liquid state, as they are fed into the chamber against the radially outermost wall of the chamber into a film of thickness not more than 150 micrometers, preferably not more than 120 micrometers, and more preferably less than 100 micrometers. The fluid is supplied at velocities of between 1 and 100 meters per second, preferably between 6 and 20 meters per second. At these speeds and corresponding centrifugal force, molecular clusters, which normally inhibit one on one molecular diffusion reaction between the reactant molecules, are disrupted by the highly sheared fluid to facilitate forced molecular interdiffusion, so that the molecules more aggressively and quickly interact with one another with considerably increased rates of reaction, e.g. 100 to 1,000 times increase. This use of an intermediate shear transmitting fluid traveling at high velocity in a circular path gives flexibility in the radial dimension of the reaction chamber, which can be as large as 10 mm radially and 6 mm longitudinally and provides one open surface of the sheared film of the reagents. | 2009-04-30 |
20090110601 | Molecularly imprinted polymers for detection in lateral flow devices - Devices, methods and kits for rapid and simple determination of target molecules, including small molecules, polypeptides, proteins, cells and infectious disease agents in liquid samples that are capable of real-time measurement of these entities in fluid samples that are highly selective, highly sensitive, simple to operate, low cost, and portable. The devices, methods and kits also provide, in at least some embodiments, the use of MIPs in a flow through or lateral flow device. | 2009-04-30 |
20090110602 | Fluid reactor having a thin film with two-dimensionally distributed micro-resistor units - A fluid reactor having a thin film with two-dimensionally distributed micro-resistor units includes one flow way, separating ribs, a thin film which is thinner than 100 micrometer, and a catalytic layer. There are multiple micro-resistor units, which is thinner than 60 micrometer each, set on the thin film. A bi-directional control unit is disposed to control these multiple micro-resistor units to shift to a desired mode selected from detecting electrical resistance, voltage, current, temperature, flow speed, and/or heat-up functions at different time. It can be applied to different kinds of fuel cells with different flow-way patterns. Its micro-resistor units have bi-directional functions. It can detect flow speed at a desired location in the flow way. It would not influence its original flow field and structure. Plus, it is easy to be installed. | 2009-04-30 |
20090110603 | Method For Detecting And Compensating An Underdosage Of Test Strips - The invention concerns a method for detecting an underdosage of an analytical test element and optionally for compensating the underdosage. The invention also concerns an analytical system and a test element which are suitable for detecting an underdosage. | 2009-04-30 |
20090110604 | Substrates for nitric oxide releasing devices - The present disclosure relates to substrates associated with nitric oxide. | 2009-04-30 |
20090110605 | MICROCHEMICAL CHIP AND SAMPLE TREATMENT DEVICE - A microchemical chip includes: a sample loading portion for loading a sample; a driving liquid reservoir holding a driving liquid; a sample channel for communicating at least the driving liquid reservoir, the sample loading portion, an amplifying portion, and a detecting portion with each other; and a pump chamber, formed on the sample channel at a position between the driving liquid reservoir and the sample loading portion, for feeding the driving liquid to transport the sample from the sample loading portion to the amplifying portion. | 2009-04-30 |
20090110606 | DISPENSING APPARATUS AND ANALYZER - A dispensing apparatus includes a syringe that houses a liquid thereinside; and a plunger that moves forward and backward inside the syringe to thus discharge the liquid from an outlet formed in the syringe to the outside of the syringe. A hydrophilic film is formed on at least either of an inner wall of the syringe and a surface of the plunger. | 2009-04-30 |
20090110607 | LIQUID CONTAINER WITH AN EXTRACTION CHIMNEY - A liquid container with an upper opening and a tube-shaped withdrawal chimney is disclosed. The withdrawal chimney extends into the container through the upper opening which has a liquid-permeable zone in the form of a finely-porous flow resistance element in its lower end region such that liquid exchange can take place between the withdrawal chimney and the container inner space which surrounds it via the flow resistance element. A venting groove formed by a radial recess of the casing wall of the withdrawal chimney in its upper region may be provided to ensure adequate venting of the space above the liquid level. | 2009-04-30 |
20090110608 | CALIBRATION SYSTEM, MATERIAL DELIVERY SYSTEM, AND METHODS FOR SUCH DELIVERY AND CALIBRATION - Material delivery systems, methods of delivering material and methods of calibrating such systems and methods are disclosed. The material delivery system includes a delivery vessel, a load cell, and automated weight calibration device. The delivery vessel has at least an outlet adapted for coupling to an unit. The load cell is configured to provide a metric indicative of an amount of material in the delivery vessel. The automated weight calibration device is configured to impart a known force onto the at least one load cell. A method includes delivering material to a unit and determining how much material is delivered by a change in weight of a delivery vessel, wherein the delivery vessel comprises a load cell; applying a known calibration force to the load cell; and comparing a metric from the load cell of the known calibration with an expected metric. | 2009-04-30 |
20090110609 | Pressurization Device And Air Treatment System For A Shelter - A pressurization device is for a flexible enclosure disposable within an environment having air at a pressure and configured to define an interior chamber having a sufficient volume to entirely contain at least one person and containing air. The device includes a gas generator configured to generate and release a gas into the enclosure chamber such that the enclosure air pressure is increased or maintained above the environment air pressure to prevent entry of environment air into the enclosure chamber. The generator is preferably configured to generate the gas by a chemical reaction, and preferably includes a quantity of at least one reactant, such as sodium nitrate, sulfuric acid or ammonium chloride, and initiates chemical reaction of the reactant to generate the gas. Furthermore, the pressurization device is preferably incorporated into an air treatment system including an oxygen generator that generates and discharges oxygen into the enclosure chamber. | 2009-04-30 |
20090110610 | DEODORIZATION DEVICE OF COOKING APPARATUS AND COOKING APPARATUS INCLUDING DEODORIZATION DEVICE - A deodorization device of a cooking apparatus includes a first discharge unit disposed to intersect a flow path along which air including odor-producing materials passes, the first discharge unit having a plurality of first through holes through which the air passes; and a second discharge unit spaced apart from the first discharge unit so as to form a discharge space there between in which the air is deodorized, the second discharge unit having a plurality of second through holes through which the air from the discharge space passes. | 2009-04-30 |
20090110611 | Fan capable of giving fragrant smell - A fan includes a motor holding member, and a fragrance giving device; the motor holding member has a slot and several vent holes thereon; the fragrance giving device includes a first shell-shaped member, a second shell-shaped member, and a fragrant unit pressed between the first and the second shell-shaped members; the fragrance giving device is inserted in the motor holding member through the slot in order for the fragrant unit to face the vent holes; therefore, when the fan is running, it can give off fragrant smell, which will be carried with the wind produced by the fan, thus making the room full of fragrant air. | 2009-04-30 |
20090110612 | Nitric oxide permeable housings - The present disclosure relates to an apparatus that includes one or more nitric oxide permeable housings. | 2009-04-30 |
20090110613 | Vessel sterilization apparatus - A vessel sterilizing apparatus includes a vessel conveying unit for conveying a vessel, and an electron beam irradiation unit for irradiating the vessel with an electron beam. The sterilizing apparatus further includes a sterilization area in which the vessel is irradiated with the electron beam, a first chamber surrounding the sterilization area so as to separate the sterilization area from an external portion, a supply area disposed upstream side of the sterilization area in a vessel conveying direction and provided with an opening through which the vessel passes, a second chamber surrounding the supply area so as to separate the supply area from an external portion, and a sterilizing medium supplying unit for supplying a sterilizing medium to the supply area. | 2009-04-30 |
20090110614 | Syringe, system and method for delivering oxygen-ozone - In accordance with at least one exemplary embodiment, a syringe, method and system for delivering a therapeutic amount of ozone are disclosed. An exemplary syringe can have a gas chamber and one or more electrodes. A portion of at least one electrode can be within the gas chamber. Alternatively, singularly or in conjunction, one or both electrodes can be attached to the outside of an exemplary syringe. One or more electrical contact points can be outside the gas chamber. Each electrical contact point can be connected to an electrode. Oxygen gas can provided within the gas chamber of the exemplary syringe. A medical ozone generator can be connected to the syringe via the electrical contact points. Corona discharge can be effectuated via the electrodes, which can result in an amount of ozone gas can being produced from the oxygen gas. | 2009-04-30 |
20090110615 | Segmented Outer Catalyst Retention Screen for Stacked Radial Flow Reactors - A radial flow reactor design is presented. The reactor has individual and interchangeable screens that are arrayed circumferentially around the inside of the reactor. The reactor includes a plurality of screens held out from the reactor wall to form a circumferential screen, with channels defined between the reactor wall and the circumferential screen. | 2009-04-30 |
20090110616 | METHOD AND APPARATUS FOR IMPROVING RADIAL FLOW MOVING BED REGENERATION/REACTION SYSTEM PERFORMANCE - An improved radial or cross flow moving bed regenerator or reactor, in which the solid particle residence time in the vessels can be changed in different section of the regenerator or reactor. The improvement results from the placement of one or multiple screen inserts which divides the radial or cross flow bed into separate solid flow channels. The residence time of the solid in each solid flow channels are optimized based on the regeneration or reaction requirement by changing the location, orientation and geometry of the screen inserts. As a result of the optimization of solid residence time in different section in the radial flow bed, the efficiency of a regenerator or a reactor is improved. | 2009-04-30 |
20090110617 | Radial Flow Reactor Design for High Volumetric Flows - A new radial flow reactor design is presented. The design includes a plurality of cylindrically shaped beds wherein the beds are sized to be nested one within another, and the beds are disposed within a housing. | 2009-04-30 |
20090110618 | SINK DRAIN DEODORIZER STICK - A solid chemical stick for treating a kitchen sink drain pipe. The solid chemical stick has dimensions that enable it to fit through a drain guard but prevent the stick from moving beyond the drain trap. The stick diminishes in size as it dissolves until it is swept away by drain water passing through the drain pipe. | 2009-04-30 |
20090110619 | Apparatus for manufacturing metal nanoparticles - An apparatus for manufacturing metal nanoparticles is disclosed. The apparatus includes: a precursor supply unit configured to supply a precursor solution for metal nanoparticles, a transport device configured to transport the precursor solution, a heating unit connected with the precursor supply unit and configured to heat the precursor solution to a temperature range in which a production of metal nanoparticles occurs, and a cooling unit connected with the heating unit and configured to collect and cool metal nanoparticles produced at the heating unit, where the cooling unit includes: a channel, a tube surrounding the channel, and a circulator configured to supply a coolant to the tube. | 2009-04-30 |
20090110620 | PROCESS FOR METALS RECOVERY FROM SPENT CATALYST - The process of this invention is directed to the removal of metals from an unsupported spent catalyst. The catalyst is subjected to leaching reactions. Vanadium is removed as a precipitate, while a solution comprising molybdenum and nickel is subjected to further extraction steps for the removal of these metals. Molybdenum may alternately be removed through precipitation. | 2009-04-30 |
20090110621 | TREATMENT OF ENGINE EXHAUST USING BORON-CONTAINING MOLECULAR SIEVE CHA - A boron-containing molecular sieve having the CHA crystal structure and comprising (1) silicon oxide and (2) boron oxide or a combination of boron oxide and aluminum oxide, iron oxide, titanium oxide, gallium oxide and mixtures thereof is prepared using a quaternary ammonium cation derived from 1-adamantamine, 3-quinuclidinol or 2-exo-aminonorbornane as structure directing agent. | 2009-04-30 |
20090110622 | METHODS AND APPARATUS FOR SMART ABATEMENT USING AN IMPROVED FUEL CIRCUIT - A method for abating effluent from an electronic device manufacturing process is provided, including abating the effluent in a thermal abatement tool to form abated effluent; determining whether the abated effluent contains one or more chemical species of interest; and changing one or more operating parameters of the thermal abatement tool based upon the determination. Numerous other embodiments are provided. | 2009-04-30 |
20090110623 | Siloxane Resistant Ultra Violet Photocatalysts - Deactivation resistant photocatalysts can be formulated by coating one or more photocatalyst crystals onto a suitable substrate. The photocatalyst crystals are doped with a dopant M. The dopant could be used to repel the silicon-based compound or be used to attract the silicon-based compound. In one embodiment, the dopant can uniformly be distributed in the photocatalyst crystals. In another embodiment, the dopant can be introduced only to photocatalyst crystals between about 0.1 to about 2 nanomenters below the surface of the structure. In another embodiment, the doped photocatalyst crystals can be interdispersed with non-doped photocatalyst crystals. | 2009-04-30 |
20090110624 | Processes for Producing Phosphates - There are disclosed methods for producing ammonium, sodium, and/or potassium phosphates that involve reacting phosphate rock with ammonium, sodium and/or potassium hydrogen sulfate. | 2009-04-30 |
20090110625 | Novel Aluminum Complex Hydroxide Salt and Method of Producing the Same - An aluminum complex hydroxide salt having Al oxide octahedral layers and a divalent anion among the octahedral layers, wherein an aluminosilicate anion expressed by the following general formula (1), | 2009-04-30 |
20090110626 | Low Pressure Method of Annealing Diamonds - The present invention relates to method of improving the optical properties of diamond at low pressures and more specifically to a method of producing a CVD diamond of a desired optical quality which includes growing CVD diamond and raising the temperature of the CVD diamond from about 1400° C. to about 2200° C. at a pressure of from about 1 to about 760 torr outside the diamond stability field in a reducing atmosphere for a time period of from about 5 seconds to about 3 hours. | 2009-04-30 |
20090110627 | GRAPHENE SHEET AND METHOD OF PREPARING THE SAME - An economical method of preparing a large-sized graphene sheet having a desired thickness includes forming a film, the film comprising a graphitizing catalyst; heat-treating a gaseous carbon source in the presence of the graphitizing catalyst to form graphene; and cooling the graphene to form a graphene sheet. A graphene sheet prepared according to the disclosed method is also described. | 2009-04-30 |
20090110628 | Method for preparing porous fabrics - A method for preparing porous fabrics is disclosed. The method includes transporting PAN-based oxidized fabrics to a thermal treatment chamber, which provides multi-pipe to introduce oxygenated gas and oxygenated fluid respectively, by using a plurality set of rollers to carry out an activation-carbonization process. The activation-carbonization process is preformed within a temperature range of 1010° C. to 1500° C., and produced the porous activated carbon fabrics that provide uniform nano-pore with BET surface area about 800˜1500 m2/g. | 2009-04-30 |
20090110629 | Method for Producing High Purity Caustic Potash - The present invention contemplates for providing a producing method which can give highly pure caustic potash in a relatively simple process, in response to the above-described demand for increased high purity in caustic potash. | 2009-04-30 |
20090110630 | METHOD OF MANUFACTURING VANADIUM OXIDE NANOPARTICLES - Disclosed is a method of manufacturing vanadium oxide nanoparticles, which can prepare vanadium oxide particles having a size of tens of nanometers with high yield by using a simple, low-cost process. The method of manufacturing vanadium oxide nanoparticles includes preparing a solution containing a vanadium salt; impregnating an organic polymer including a nanosized pore with the prepared solution; and heating the organic polymer impregnated with the vanadium salt solution until the organic polymer is fired. | 2009-04-30 |
20090110631 | Methods of recovery of pore-forming agents for mesostructured materials - The invention provides methods of recovering a pore-forming agent from an inorganic material that defines a plurality of mesopores having a controlled cross sectional area to form a mesostructure having long-range crystallinity and also to methods of making one or more mesostructures that features removal, recovery, and/or reuse of the pore-forming agent. Suitable pore-forming agents include, for example, surfactants. | 2009-04-30 |
20090110632 | BIOLOGICAL MATERIALS AND USES THEREOF - There is provided by the invention a modified antibody molecule which selectively binds to a specific target, the antibody molecule being modified at, at least one amino acid residue that forms part of a glycosylation site in the variable region of an unmodified parent antibody molecule, characterised in that the modified antibody is not glycosylated at the previous glycosylation site of which the amino acid modification forms part and the modified antibody exhibits a greater binding affinity for the specific target than the unmodified parent antibody molecule. There is also provided nucleotide sequences, amino acid sequences and expression vectors encoding the modified antibodies, and uses thereof. | 2009-04-30 |
20090110633 | Nanocells for Diagnosis and Treatment of Diseases and Disorders - The present invention relates to novel nanocell compositions and their use in imaging, diagnostic and treatment methods. In one embodiment, nanocells tailored for imaging methods comprise a nanocore surrounded by a lipid matrix, and are modified to contain a radionuclide core or a nanocore with an emission spectra. The nanocells may be size restricted such as being greater than about 60 nm so that they selectively extravasate at sites of angiogenesis (e.g. tumor) and do not pass through normal vasculature or enter non-tumor bearing tissue. In this way, angiogenic sites can be both detected and treated. In another embodiment, nanocells are tailored for various treatment methods, including the treatment of brain cancer, asthma, Grave's Disease, Cystic Fibrosis, and Pulmonary Fibrosis. | 2009-04-30 |
20090110634 | RADIOLABELLED NANOPARTICLES - The present invention relates to radiolabelled nanoparticles having a radioisotope non-covalently bonded thereto. The radiolabelled nanoparticles are useful as radiopharmaceuticals. Kits and methods of preparation of the radiolabelled nanoparticles are also disclosed. | 2009-04-30 |
20090110635 | METHODS FOR IMAGING DOPAMINE TRANSPORTER LEVEL - Presented is a method for assessing dopamine transporter levels in a selected area of a subject's central nervous system by SPECT imaging comprising administering an injection of a labeled dopamine transporter ligand at approximately the time the subject is positioned for SPECT imaging and initiating a SPECT acquisition for a duration of about 30 minutes commencing at about 15 minutes after administration of labeled dopamine transporter ligand; and assessing, based on said SPECT acquisition, the amount of labeled dopamine transporter ligand that is bound to dopamine transporter. | 2009-04-30 |
20090110636 | FLUORINATED DIHYDROTETRABENAZINE ETHER IMAGING AGENTS AND PROBES - The present invention provides novel fluorinated ether compounds having structure I | 2009-04-30 |
20090110637 | LMP and Regulation of Tissue Growth - Novel methods are provided for changing cell phenotype, comprising a method of changing a phenotype of a target cell comprising: increasing an amount of an amino acid sequence in a source cell, wherein the source cell is located within a volume of a media and wherein the amino acid sequence is selected from the group consisting of LMP-1 protein, an LMP-2 protein, an LMP-3 protein, an LMP-1s protein, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 or combination thereof; collecting at least a portion of the volume of the media; and contacting the target cell with at least the portion of the media. | 2009-04-30 |
20090110638 | METHODS USING THE GRUENEBERG GANGLION CHEMOSENSORY SYSTEM - The present invention relates to physical and pharmaceutical methods of increasing or decreasing the activity of the Grueneberg Ganglion (GG) in a subject. In one embodiment, the method comprising administering a compound to the GG, wherein the compound is an agonist or antagonist, respectively, for at least one guanylyl cyclase receptor or the receptor's downstream effectors. The present invention also relates to methods of screening candidate compounds for their ability to modulate the activity of the GG. The present invention also relates to methods and kits for positively identifying a GG neuron based upon the presence or absence of the pGC-G or pGC-A receptors. | 2009-04-30 |
20090110639 | PREDICTING VACCINE EFFICACY - The present invention provides methods for evaluating a vaccine, combinations of tests and reaction mixtures that can be used as part of such methods, and collections of results comprising results obtained from such methods. The methods, combinations, and collections are useful for determining whether a vaccine is effective and, for example, for comparing the efficacy of different vaccines. | 2009-04-30 |
20090110640 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY CONSISTING OF A CYCLIC OLIGOAMID CORE OF 3 TO 4 IDENTICIAL MONOMER UNITS WITH 3 TO 4 PARAMAGNETIC CHELATE SIDE CHAINS - The present invention relates to: Compounds of formula (I) consisting of a cyclic polymer core A and groups -L-X attached to said core A-(L-X) | 2009-04-30 |
20090110641 | METHOD AND APPARATUS FOR NON-INVASIVE MEASUREMENT OF SKIN TISSUE CHOLESTEROL - The present invention provides a method and apparatus for non-invasive measurement of skin cholesterol. More particularly, one aspect of the invention provides for a device to apply a detector reagent to a selected area of skin. Another an indicator device to produce a visual change corresponding to the amount of detector reagent that is bound in the skin. The method and apparatus of this invention typically do not require any instrumentation for certain embodiments, allowing the invention to be suitable for self-testing, for example, but not limited to, in the home environment. As such the invention is particularly useful to allow individuals to assess their risk of atherosclerosis and related vascular diseases. | 2009-04-30 |
20090110642 | METHOD FOR THE PRODUCTION OF BIO-IMAGING NANOPARTICLES WITH HIGH YIELD BY EARLY INTRODUCTION OF IRREGULAR STRUCTURE - Methods of preparing bio-imaging nanoparticles having high dispersibility in an aqueous solution, biocompatibility, and targetability with high yield, by early introduction of an irregular structure are disclosed. | 2009-04-30 |
20090110643 | Method of Producing Liposomes Containing Gas Enclosed Therein - Gas-filled liposomes that are useful for ultrasonography and ultrasound therapy are provided. A method of producing the gas-filled liposomes, including filling the void space in a sealed container containing a liposome suspension in a volume amounting to 20 to 80% of the inner capacity thereof with a fluoride gas or a nitrogen gas, and subjecting the container to an ultrasonication. | 2009-04-30 |
20090110644 | Polymer nanoparticles coated by magnetic metal oxide and uses thereof - The invention provides nanoparticles consisting of a polymer which is a metal chelating agent coated with a magnetic metal oxide, wherein at least one active agent is covalently bound to the polymer, said nanoparticles may optionally further comprise at least one active agent physically or covalently bound to the outer surface of the magnetic metal oxide. Pharmaceutical compositions comprising these nanoparticles may be used, inter alia, for detection and treatment of tumors and inflammations. | 2009-04-30 |
20090110645 | Use of metal astringents for the treatment and prevention of hairy heel warts - A system and method for treating hoof related diseases, particularly hairy heel warts (papillomatus digital dermatitis), includes an aqueous solution having a metal astringent at a therapeutically effective concentration. The metal astringent includes aluminum, iron, and mixtures thereof. In preferred embodiments, the metal may include a mixture of monomeric and polymeric species. The polymeric species may be in the form of a polymeric concentrate, such as, for example, polyaluminum chloride or polyferric sulfate. Alternatively, the polymeric species may be formed by partially neutralizing a metal salt. The aqueous solution of the metal astringent is applied to a lower leg and hoof area of an animal using any known application technique, including, but not limited to, foot baths, foams and spray applications. In preferred embodiments, the aqueous solution is applied using an automated dispensing system. The aqueous solution may include additional components, such as surfactants and thickeners, to enhance the performance of the metal astringent or contribute additional functionality. | 2009-04-30 |
20090110646 | Product for Treating the Skin and Mucous Membranes, and Relative Method of Preparation - A method for preparing a product for treating the skin and mucous membranes comprises the steps of making available a suitable quantity of trichloracetic acid, making available a suitable quantity of hydrogen peroxide, making a first mixture of the trichloracetic acid and the hydrogen peroxide, making available a determinate quantity of the basic compound able to achieve a buffer effect of the trichloracetic acid comprised in the first mixture, and adding the basic compound. | 2009-04-30 |
20090110647 | METHOD OF PREVENTING ADVERSE EFFECTS BY GLP-1 - A method for preventing or reducing adverse effects such as profuse sweating, nausea and vomiting, which normally are associated with subcutaneous and intravenous administration of glucagon-like peptide 1 (GLP-1) therapy is provided. In particular, the method comprises the rapid administration of a GLP-1 formulation into the pulmonary circulation such as by inhalation, directly into pulmonary alveolar capillaries using a dry powder drug delivery system. | 2009-04-30 |
20090110648 | Chocolate Flavored Dentifrice With New Visuals - A multi-phase dentifrice composition is provided, comprising an orally acceptable carrier and a chocolate flavoring, wherein, using the CIE L*a*b* color scale, a first phase of the composition has an L* value of at least about 75, an a* value from about −8 to about 8, and a b* value from about 0 to about 5, and a second phase of the composition has an L* value of at most about 65, an a* value from about 0 to about 12, and a b* value from about 0 to about 15. | 2009-04-30 |
20090110649 | ANTIPRURITIC COSMETIC AND DERMATOLOGICAL PREPARATIONS - A topical cosmetic or dermatological preparation which is effective for treating a pruritic condition, is present as a non-ionic O/W emulsion, and comprises water, one or more oil phases, PEG 12 cetearylether and/or PEG 40 monostearate, polidocanol, menthol, and one or more O/W emulsifiers or co-emulsifiers. | 2009-04-30 |
20090110650 | Photoprotective Composition and Screening Agents for Said Composition - The present invention concerns a photoprotective composition comprising at least one interferential screening agent screening UVA and/or UVB. | 2009-04-30 |
20090110651 | Cosmetic Composition Comprising A Combination of a Sugar Fatty Acid Ester with a Plant Extract of Waltheria Indica or Pisum Sativum for Skin Whitening - The invention is directed to a skin-whitening active comprising at least one sugar fatty acid ester and at least one plant extract selected from the group consisting of extracts of | 2009-04-30 |
20090110652 | Polyglycerol dimer polyester resins - The present invention relates to a series of novel polyesters that are prepared by crosslinking polyglycerol and dimer acid. The nature of the water loving polyglycerol group as well as the fact that a C-36 fatty diacid is used in preparation of the products results in unique products. | 2009-04-30 |
20090110653 | Fluoro silicone polyester resins - The present invention relates to a series of novel silicone polyesters which are prepared by crosslinking an fluoro dimethicone copolyol with a dimer acid. The reaction of the fluoro dimethicone copolyol and dimer acid results in a polyester having affinity to oils and that is highly lubricious on hair, skin and textile fiber. | 2009-04-30 |
20090110654 | Bio-Plastic Composite Material, Method of Making Same, And Method of Using Same - A bio-plastic composite comprises at least one biological material and one plastic material. The biological material in the bio-plastic composite is hydrolyzed, classified, or cryogenically ground for enhanced integration with the plastic material. A bio-odor generated during process of making bio-plastic composites is counter acted or masked by integrating odor controlling agents into bio-plastic composites. | 2009-04-30 |
20090110655 | PROPHYLACTIC AND/OR THERAPEUTIC DRUG FOR NONALCOHOLIC STEATOHEPATITIS - The present invention provides a method for the treatment of nonalcoholic steatohepatitis with a pharmaceutically acceptable anion exchange resin such as, for example, colestimide. | 2009-04-30 |
20090110656 | Skin cooling composition - A cooling composition for application to the skin of a mammal, such as a human. The base of the composition is an interpenetrating polymer network, which may contain a thermo-responsive polymer. Having a Critical Temperature above an average core body temperature, the material may undergo a phase change as the creature becomes too warm, such as when a person experiences a hot flash, a fever, exposure to very warm environments, physical exertion, and the like. The phase change results in a cooling and/or cooling sensation of the skin. Additives may be included in the cooling composition such as evaporative cooling components, neurosensory cooling components, and additional phase change components. | 2009-04-30 |
20090110657 | Skin care compositions - Provided are compositions which are suitable for topical application to mammalian skin for cleansing and anti-microbial properties. In one embodiment, the compositions include an ester of polyalkylene glycol monoazelate monolaurate. It is postulated that bacteria on or in the skin may cleave the ester linkage of a compound according to the present disclosure that is applied to the skin, which causes liberation of the acid moiety from the ester, which acid moiety then inhibits or kills the bacterium. Compositions according to the present disclosure may comprise skin creams, soaps, shampoos and lotions, and are especially effective in treating acne and acne-like skin ebullitions. | 2009-04-30 |
20090110658 | ANTIFOULING CONDENSATION CURING ORGANOPOLYSILOXANE COMPOSITION, MAKING METHOD, AND UNDERWATER STRUCTURE - An antifouling condensation curing organopolysiloxane composition is prepared by premixing a part or all of (A) a diorganopolysiloxane free of a reactive group with a part or all of (B) silica to form a premix, then mixing the premix with the remainder of (A) and (B), (C) a base diorganopolysiloxane, and (D) a silane. The composition has a good balance of low viscosity and high thixotropy, can be thickly coated in a single pass, and cures into a coating having rubber strength and surface smoothness and exhibiting satisfactory antifouling property over a long period of time. | 2009-04-30 |
20090110659 | Human chemotactic cytokine - The invention relates to isolated and/or recombinant nucleic acids which encode a human chemotactic cytokine designated human eotaxin, and to isolated and/or recombinant human eotaxin proteins or polypeptides, including synthetic polypeptides. The invention further relates to recombinant nucleic acid constructs, comprising a nucleic acid which encodes a human eotaxin, a portion thereof, or a variant; to host cells comprising such constructs, useful for the production of recombinant human eotaxin; and to antibodies reactive with human eotaxin, useful in in vitro methods, diagnosis and/or therapy. Also provided are methods of use of the eotaxin proteins, e.g., in the recruitment of eosinophils to a particular site or in the treatment of allergic conditions. Human eotaxins can be used to identify inhibitors (e.g., antagonists) or promoters (agonists) of human eotaxin, which can be used to selectively modulate leukocyte function, in inflammatory and autoimmune diseases, or in infections. | 2009-04-30 |
20090110660 | Combination of an anti-ED - B fibronectin domain antibody - IL-2 fusion protein and gemcitabine - The invention refers to the use of L19IL2 for treatment of pancreatic cancer. In another embodiment, the invention relates to a combination (i) of a fusion protein, comprising an Interleukin 2 part and an antibody part, specifically recognising the extra domain B of fibronectin (ED-B-fibronectin), and (ii) gemcitabine. | 2009-04-30 |
20090110661 | Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity - The present application relates to novel methods for treating obesity. Some aspects pertain to the use of gene therapy to treat diseases related to metabolic dysfunction, such as diabetes, obesity, high blood pressure, and atherogenic dyslipidemia. The present application also pertains to the use of vectors such as a recombinant adeno-associated virus (AAV) to deliver a gene that can increase or decrease expression of a therapeutic protein of interest, e.g., in cells in a specific region of the brain associated with metabolic dysfunction. The present application also discloses the use of vectors such as a recombinant adeno-associated virus for the delivery of small interference RNA's (siRNAs) capable of decreasing expression of a deleterious protein involved in the disorder. Other related aspects, including compositions related to such methods, are also disclosed. | 2009-04-30 |
20090110662 | MODIFICATION OF BIOLOGICAL TARGETING GROUPS FOR THE TREATMENT OF CANCER - The present invention relates to the field of polymer chemistry and more particularly to click-functionalized targeting compounds and methods for using the same. | 2009-04-30 |
20090110663 | Method for treatment of bowel disorders - A composition and method for treatment for bowel disorders is described. The composition consists of two parts. First, highly purified, insoluble, chemically unmodified fiber from plants is mixed with an aqueous solution such as water. The second component of the composition is a commercially available probiotic preparation. These commercially probiotic preparations contain large numbers of viable microorganisms of either | 2009-04-30 |
20090110664 | PROBIOTIC COMPOSITIONS AND METHODS FOR INDUCING AND SUPPORTING WEIGHT LOSS - A probiotic composition for inducing or supporting weight loss in a subject, the probiotic composition including an effective amount of a bacteria selected from the genus | 2009-04-30 |
20090110665 | REOVIRUS FOR THE TREATMENT OF NEOPLASIA - Methods for treating neoplasia, by administering reovirus to a Ras-mediated neoplasm, are disclosed. The reovirus is administered so that it ultimately directly contacts cells of the neoplasm. Human reovirus, non-human mammalian reovirus, and/or avian reovirus can be used. If the reovirus is human reovirus, type 1 (e.g., strain Lang), type 2 (e.g., strain Jones), type 3 (e.g., strain Dearing or strain Abney), as well as other serotypes or strains of reovirus can be used. Combinations of more than one type and/or strain of reovirus can be used, as can reovirus from different species of animal. Either solid neoplasms or hematopoietic neoplasms can be treated. | 2009-04-30 |
20090110666 | Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours - The invention described herein refers to derivatives of the long pentraxin PTX3 with the sequence indicated in the text, capable of binding to the membranes of inactivated tumour cells. The inactivated tumour cells, bearing on their surface a derivative of PTX3 are used to prepare an autologous vaccine for the treatment of tumours. | 2009-04-30 |
20090110667 | DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS - Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing the involving a PD1 ligand. | 2009-04-30 |
20090110668 | SUBPOPULATIONS OF BONE MARROW-DERIVED ADHERENT STEM CELLS AND METHODS OF USE THEREFOR - The presently disclosed subject matter provides an isolated subpopulation of bone marrow-derived adherent stem cells that are purified from bone marrow-derived adherent cells. Also provided are methods for isolating the subpopulation of bone marrow-derived adherent stem cells from bone marrow-derived adherent cells and for using the isolated subpopulation of bone marrow-derived adherent stem cells for treating tissue and/or organ damage in a subject. | 2009-04-30 |
20090110669 | METHODS FOR IMPROVING CELL LINE ACTIVITY IN IMMUNOISOLATION DEVICES - Methods for maintaining and improving the secretory activity of cells housed in immunoisolation devices. | 2009-04-30 |
20090110670 | Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter - Strains of | 2009-04-30 |
20090110671 | AGENT FOR ENHANCHING THE PRODUCTION OF COLLAGEN AND IT'S USE - The present invention has an object to provide a means for durably exerting an action of enhancing collagen-production, and the object is attained by providing a collagen-production enhancer which contains, as an effective ingredient, α,α-trehalose and/or a saccharide derivative thereof, and by a composition incorporated with the collagen-production enhancer to be used for such purpose. | 2009-04-30 |
20090110672 | Angiogenic Tyrosyl tRNA Synthetase Compositions and Methods - The present invention provides an isolated tyrosyl tRNA synthetase (TyrRS) polypeptide variant which comprises (a) a Rossmann fold region or a portion thereof, preferably including an 5 coil; and (b) an anticodon recognition domain or portion thereof, preferably including an 14 coil. Preferably, the 5 coil and the 14 coil have a greater spatial separation in the tertiary structure of the variant compared to the corresponding spatial separation in native human TyrRS. The variant preferably comprises an amino acid residue sequence identity of at least about 50% compared to the amino acid residue sequence of human TyrRS (SEQ ID NO: 3), includes at least one non-conservative amino acid residue sequence of human TyrRS, and preferably presents an exposed ELR motif in the 5 coil on an external portion of the tertiary structure of the polypeptide. A preferred TyrRS protein variant comprises the amino acid residue sequence of SEQ ID NO: 4 or a portion thereof. The proteins and protein fragments of the invention are angiogenic and are useful for stimulating angiogenesis in mammalian tissues. | 2009-04-30 |
20090110673 | METHODS OF REDUCING CELL DEATH FOLLOWING HYPOXIA / REOXYGENATION - Provided are methods of reducing cell death, attenuating a burst of reactive oxygen species, reducing cytotoxicity, reducing intracellular oxidant stress due species in a population of cells following hypoxia by reoxygenating the cells in the presence of a reversible electron transport chain inhibitor or under hypercarbic conditions. Also provided is a method to determine the effectiveness of a reversible electron transport chain inhibitor for reducing cell death in a population of cells. | 2009-04-30 |
20090110674 | Health supplement - A health supplement consisting of numerous ingredients from several general groups including: anti-aging, anti-oxidant, vitamins, minerals, and elemental substances including metals. The supplement is specifically formulated for maximizing synergistic interaction of the ingredients while eliminating harmful interaction among the ingredients. A holistic approach to health is followed with ingredients to aid all systems of the human body. By addressing all human body systems, the supplement acts as a precursor to anti-aging and, when body systems are detoxified and oxidation is controlled, the effect of aging may be reversed. | 2009-04-30 |
20090110675 | USE OF PLATELET ACTIVATING FACTOR ACETYLHYDROLASE AS BIOMARKER FOR ANAPHYLAXIS - A method for determining a patient's susceptibility to anaphylaxis comprises assaying the activity of platelet activating factor acetylhydrolase (PAF-AH) activity and comparing the measured activity to a reference value, wherein the level of PAF-AH activity inversely correlates with the susceptibility to anaphylaxis. The method further comprises determining the severity of anaphylaxis by correlating the degree of reduced PAF-AH activity to the reference value. The method further comprises measuring IgE concentration and comparing the measured concentration to a reference concentration. The invention further provides a method for diagnosing anaphylaxis in a patient comprising measuring the serum concentration of platelet activating factor (PAF) and comparing the measured concentration to a reference value, wherein the concentration of PAF correlates directly with severity of anaphylaxis. The invention also provides a kit for performing the required assay or assays. | 2009-04-30 |
20090110676 | BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders - The invention provides methods for treating or preventing disorders associated with expression of BAFF comprising BAFF and fragments thereof, antibodies, agonists and antagonists. | 2009-04-30 |